Literature DB >> 15833406

Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances.

Gary M Strauss1.   

Abstract

This article discusses methodologic issues relevant to the interpretation of recent studies focusing on adjuvant chemotherapy of lung cancer. It also attempts to conclude where we currently stand in this field.

Entities:  

Mesh：

Year:  2005        PMID： 15833406     DOI： 10.1016/j.hoc.2005.02.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  15 in total

1.  The role of gene expression profiling in early-stage non-small cell lung cancer.

Authors:  Wenlong Shao; Daoyuan Wang; Jianxing He
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

Review 2.  Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.

Authors:  Misako Nagasaka; Shirish M Gadgeel
Journal:  Expert Rev Anticancer Ther       Date:  2017-11-26       Impact factor: 4.512

3.  Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.

Authors:  Jing Wang; Jun Qian; Megan D Hoeksema; Yong Zou; Allan V Espinosa; S M Jamshedur Rahman; Bing Zhang; Pierre P Massion
Journal:  Clin Cancer Res       Date:  2013-08-01       Impact factor: 12.531

4.  Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.

Authors:  Jaya Sangodkar; Analisa DiFeo; Lauren Feld; Romina Bromberg; Rachel Schwartz; Fei Huang; Esteban A Terzo; Aisha Choudhri; Goutham Narla
Journal:  Lung Cancer       Date:  2009-03-28       Impact factor: 5.705

5.  miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.

Authors:  Yueyang Bi; Yong Han; Haiyang Bi; Fuquan Gao; Xiaozhi Wang
Journal:  Hum Cell       Date:  2013-11-17       Impact factor: 4.174

6.  A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.

Authors:  Analisa DiFeo; Lauren Feld; Estefania Rodriguez; Christine Wang; David G Beer; John A Martignetti; Goutham Narla
Journal:  Cancer Res       Date:  2008-02-04       Impact factor: 12.701

7.  Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer.

Authors:  Lei Shen; Xiaoguang Wu; Jinjing Tan; Meng Gu; Yu Teng; Zitong Wang; Wentao Yue
Journal:  Onco Targets Ther       Date:  2017-07-18       Impact factor: 4.147

8.  A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.

Authors:  Mingwei Chen; Baoquan Liu; Jianbing Xiao; Yingnan Yang; Yafang Zhang
Journal:  Oncotarget       Date:  2017-02-28

9.  BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

Authors:  Rafael Rosell; Marcin Skrzypski; Ewa Jassem; Miquel Taron; Roberta Bartolucci; Jose Javier Sanchez; Pedro Mendez; Imane Chaib; Laia Perez-Roca; Amelia Szymanowska; Witold Rzyman; Francesco Puma; Grazyna Kobierska-Gulida; Raffaele Farabi; Jacek Jassem
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

Review 10.  Adjuvant chemotherapy of non-small-cell lung cancer.

Authors:  J Y Douillard
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.